Robert Bosch Venture Capital investiert in Medizintechnik-Startup Optomed

OPTOMED ANNOUNCES NEW INVESTMENT FROM RBVC

Optomed Oy, Finland based and the world’s fastest growing retinal company received significant investment from Robert Bosch Venture Capital GmbH (RBVC), Germany.

“This investment will be used to accelerate growth across the business, to advance our product development and help us to successfully execute our strategy. It is a big recognition towards both our technology and our team in Finland. We are proud to welcome RBVC as one of our investors. With their support we are growing into a truly global company,” says Seppo Kopsala, CEO of Optomed.

“Worldwide increase of chronic diseases as Diabetes leading to severe eye diseases in developed countries and emerging markets requires retina screening solutions. In order to diagnose and successfully treat such diseases in early stages it helps to reduce or prevent blindness. The Optomed approach convinced us as it offers a least cost approach with excellent technical performance on a worldwide basis. It opens huge opportunities,” says Dr. Dieter Kraft, Investment Partner of RBVC.

Optomed provides most affordable and effective fundus screening and diagnostics products and solutions that can reach all people in the world and help eye care professionals in prevention of blindness. Optomed’s products are being used by private clinics, public hospitals, non-government organizations and charities around the world, and are registered and marketed in all major markets: Europe, China, Russia, Japan, Korea, US, India and Brazil.
About Optomed Oy

Optomed Oy is an innovative Finnish medical technology company that specializes in retinal imaging devices and solutions. The product portfolio consists of unique digital imaging instruments that provide retinal and eye anterior imaging with one portable device. Optomed’s key product is Smartscope® PRO, a modular hand-held retinal camera for screening and diagnosis of various eye diseases, such as diabetic retinopathy, glaucoma and AMD. It is the smallest product on the market with high image quality which fulfills international ISO 10940 fundus camera standard requirements. Further information at: www.optomed.com
About Robert Bosch Venture Capital GmbH (RBVC)

Robert Bosch Venture Capital GmbH (RBVC) is the corporate venture capital company of the Bosch Group, a leading global supplier of technology and services. RBVC invests worldwide in innovative start-up companies at all stages of their development. Its investment activities focus on technology companies working in areas of business of current and future relevance for Bosch, above all, automation and electrification, energy efficiency, enabling technologies, and healthcare systems. RBVC also invests in services and business models as well as new materials that are relevant to the above-mentioned areas of business. Further information at: www.rbvc.com

Eiweiße aus Reis – Rohstoff statt Abfall
RWTH Aachen ist neuer Gesellschafter der TLB GmbH

Ähnliche Beiträge

No results found.

Menu